<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP11708450B8W1" file="EP11708450W1B8.xml" lang="en" country="EP" doc-number="2545068" kind="B8" correction-code="W1" date-publ="20180321" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 0.1.63 (23 May 2017) -  2999001/0</B007EP></eptags></B000><B100><B110>2545068</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20180321</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>11708450.9</B210><B220><date>20110311</date></B220><B240><B241><date>20121002</date></B241><B242><date>20141010</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>312959 P</B310><B320><date>20100311</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20180321</date><bnum>201812</bnum></B405><B430><date>20130116</date><bnum>201303</bnum></B430><B450><date>20180124</date><bnum>201804</bnum></B450><B452EP><date>20170821</date></B452EP><B480><date>20180321</date><bnum>201812</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  14/22        20060101AFI20110929BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>IMMUNOGENE ZUSAMMENSETZUNG ODER IMPFSTOFF GEGEN INFEKTION ODER KRANKHEIT MIT GRAM-NEGATIVEN BAKTERIEN WIE Z.B. NEISSERIA</B542><B541>en</B541><B542>IMMUNOGENIC COMPOSITION OR VACCINE AGAINST GRAM-NEGATIVE BACTERIAL, FOR EXAMPLE NEISERIAL, INFECTION OR DISEASE</B542><B541>fr</B541><B542>COMPOSITION IMMUNOGÉNIQUE OU VACCIN CONTRE UNE INFECTION OU MALADIE CAUSÉE PAR DES BACTERIES À GRAM-NEGATIF, COMME PAR EXEMPLE NEISSERIA</B542></B540><B560><B561><text>WO-A1-00/11182</text></B561><B561><text>WO-A1-2007/148363</text></B561><B561><text>WO-A1-2010/025964</text></B561><B561><text>WO-A2-00/55327</text></B561><B561><text>WO-A2-00/71725</text></B561><B561><text>WO-A2-01/85772</text></B561><B561><text>WO-A2-99/57280</text></B561><B562><text>CHEN ET AL: "Identification and characterization of a high-affinity zinc uptake system in Neisseria gonorrhoeae.", FEMS MICROBIOLOGY LETTERS, vol. 202, no. 1, 1 August 2001 (2001-08-01), pages 67-71, XP55001190, ISSN: 0378-1097 cited in the application</text></B562><B562><text>PATZER SILKE I ET AL: "The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli", MOLECULAR MICROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 28, no. 6, 1 June 1998 (1998-06-01), pages 1199-1210, XP002453143, ISSN: 0950-382X, DOI: DOI:10.1046/J.1365-2958.1998.00883.X cited in the application</text></B562><B562><text>CAMPOY SUSANA ET AL: "Role of the high-affinity zinc uptake znuABC system in Salmonella enterica serovar typhimurium virulence", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 70, no. 8, 1 August 2002 (2002-08-01) , pages 4721-4725, XP002453141, ISSN: 0019-9567, DOI: DOI:10.1128/IAI.70.8.4721-4725.2002</text></B562><B562><text>TURNER PAUL C ET AL: "Neisserial TonB-dependent outer-membrane proteins: Detection, regulation and distribution of three putative candidates identified from the genome sequences", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 147, no. 5, 1 May 2001 (2001-05-01), pages 1277-1290, XP009121702, ISSN: 1350-0872 cited in the application &amp; DATABASE UniProt [Online] 1 October 2000 (2000-10-01), "SubName: Full=Putative TonB-dependent outer membrane receptor;", XP002641445, retrieved from EBI accession no. UNIPROT:Q9JR50 Database accession no. Q9JR50</text></B562><B562><text>VIPOND C ET AL: "Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry", HUMAN VACCINES, LANDES BIOSCIENCE, GEORGETOWN, TX, US, vol. 1, no. 2, 1 January 2005 (2005-01-01) , pages 80-84, XP008085859, ISSN: 1554-8600</text></B562><B562><text>STORK MICHIEL ET AL: "An Outer Membrane Receptor of Neisseria meningitidis Involved in Zinc Acquisition with Vaccine Potential", PLOS PATHOGENS, PUBLIC LIBRARY OF SCIENCE, SAN FRANCISCO, CA, US, vol. 6, no. 7, 1 July 2010 (2010-07-01), pages E1000969-1, XP009148766, ISSN: 1553-7366</text></B562><B562><text>ANONYMOUS: "Vaccines and related biological products advisory committee FDA Briefing Document: Use of Serum Bactericidal Antibody as an Immunological Correlate forDemonstrating Effectiveness of Meningococcal Conjugate Vaccines (SerogroupsA, C, Y, W-135) Administered to Children Less Than 2 Years of Age", FDA BRIEFING DOCUMENT, 6 April 2011 (2011-04-06), pages 1-9,</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>18152692.2</anum></dnum><date>20180122</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>DEVOS, Nathalie, Isabelle</snm><adr><str>GlaxoSmithKline Biologicals S.A.
rue de l'Institut 89</str><city>B-1330 Rixensart</city><ctry>BE</ctry></adr></B721><B721><snm>POOLMAN, Jan</snm><adr><str>GlaxoSmithKline Biologicals S.A.
rue de l'Institut 89</str><city>B-1330 Rixensart</city><ctry>BE</ctry></adr></B721><B721><snm>STORK, Michiel</snm><adr><str>Utrecht University
Padualaan 8</str><city>NL-3584 CH Utrecht</city><ctry>NL</ctry></adr></B721><B721><snm>TOMMASSEN, Johannes, Petrus, Maria</snm><adr><str>Utrecht University
Padualaan 8</str><city>NL-3584 CH Utrecht</city><ctry>NL</ctry></adr></B721><B721><snm>WEYNANTS, Vincent</snm><adr><str>GlaxoSmithKline Biologicals S.A.
rue de d'Institut 89</str><city>B-1330 Rixensart</city><ctry>BE</ctry></adr></B721></B720><B730><B731><snm>GlaxoSmithKline Biologicals S.A.</snm><iid>100825659</iid><irf>MJL/VB64166/EP</irf><adr><str>Rue de l'Institut, 89</str><city>1330 Rixensart</city><ctry>BE</ctry></adr></B731></B730><B740><B741><snm>Dalton, Marcus Jonathan William</snm><sfx>et al</sfx><iid>101447594</iid><adr><str>GlaxoSmithKline 
Global Patents (CN925.1) 
980 Great West Road</str><city>Brentford, Middlesex TW8 9GS</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>EP2011053665</anum></dnum><date>20110311</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2011110655</pnum></dnum><date>20110915</date><bnum>201137</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
